Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 352

1.

The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis.

Mumcu G, Hayran O, Ozalp DO, Inanc N, Yavuz S, Ergun T, Direskeneli H.

J Oral Pathol Med. 2007 Mar;36(3):147-52.

PMID:
17305636
[PubMed - indexed for MEDLINE]
2.

Oral health related quality of life is affected by disease activity in Behçet's disease.

Mumcu G, Inanc N, Ergun T, Ikiz K, Gunes M, Islek U, Yavuz S, Sur H, Atalay T, Direskeneli H.

Oral Dis. 2006 Mar;12(2):145-51. Erratum in: Oral Dis. 2006 May;12(3):356.

PMID:
16476035
[PubMed - indexed for MEDLINE]
3.

A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.

Mumcu G, Sur H, Inanc N, Karacayli U, Cimilli H, Sisman N, Ergun T, Direskeneli H.

J Oral Pathol Med. 2009 Nov;38(10):785-91. doi: 10.1111/j.1600-0714.2009.00803.x. Epub 2009 Jul 15.

PMID:
19614861
[PubMed - indexed for MEDLINE]
4.

Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.

Arabaci T, Kara C, Ciçek Y.

J Periodontal Res. 2009 Dec;44(6):718-25. doi: 10.1111/j.1600-0765.2008.01183.x. Epub 2008 Dec 11.

PMID:
19076988
[PubMed - indexed for MEDLINE]
5.

Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.

Matsuda T, Ohno S, Hirohata S, Miyanaga Y, Ujihara H, Inaba G, Nakamura S, Tanaka S, Kogure M, Mizushima Y.

Drugs R D. 2003;4(1):19-28.

PMID:
12568631
[PubMed - indexed for MEDLINE]
6.

Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.

Nanke Y, Kamatani N, Okamoto T, Ogiuchi H, Kotake S.

Drugs R D. 2008;9(6):455-9. doi: 10.2165/0126839-200809060-00008.

PMID:
18989994
[PubMed - indexed for MEDLINE]
7.

Assessment of minimal clinically important improvement by using Oral Health Impact Profile-14 in Behçet's disease.

Hayran O, Mumcu G, Inanc N, Ergun T, Direskeneli H.

Clin Exp Rheumatol. 2009 Mar-Apr;27(2 Suppl 53):S79-84.

PMID:
19796539
[PubMed - indexed for MEDLINE]
8.

Oral health and related quality of life status in patients from UK and Turkey: a comparative study in Behcet's disease.

Mumcu G, Niazi S, Stewart J, Hagi-Pavli E, Gokani B, Seoudi N, Ergun T, Yavuz S, Stanford M, Fortune F, Direskeneli H.

J Oral Pathol Med. 2009 May;38(5):406-9. doi: 10.1111/j.1600-0714.2009.00752.x. Epub 2009 Mar 2.

PMID:
19298505
[PubMed - indexed for MEDLINE]
9.

The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.

Lee JH, Jung JY, Bang D.

J Eur Acad Dermatol Venereol. 2008 May;22(5):590-5. Epub 2007 Dec 17.

PMID:
18093111
[PubMed - indexed for MEDLINE]
11.

[Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases].

Fontes V, Machet L, Huttenberger B, Lorette G, Vaillant L.

Ann Dermatol Venereol. 2002 Dec;129(12):1365-9. French.

PMID:
12536172
[PubMed - indexed for MEDLINE]
12.

Salivary epidermal growth factor levels in Behçet's disease and recurrent aphthous stomatitis.

Adişen E, Aral A, Aybay C, Gürer MA.

Dermatology. 2008;217(3):235-40. doi: 10.1159/000148250. Epub 2008 Jul 25.

PMID:
18663306
[PubMed - indexed for MEDLINE]
13.

Assessment of homocysteine, neopterin and nitric oxide levels in Behçet's disease.

Ozkan Y, Yardim-Akaydin S, Sepici A, Engin B, Sepici V, Simşek B.

Clin Chem Lab Med. 2007;45(1):73-7.

PMID:
17243919
[PubMed - indexed for MEDLINE]
14.

The significance of serum nitric oxide levels in Behçet's disease and recurrent aphthous stomatitis.

Yildirim M, Baysal V, Inaloz HS, Doguc D.

J Dermatol. 2004 Dec;31(12):983-8.

PMID:
15801262
[PubMed - indexed for MEDLINE]
15.

Does recurrent aphthous stomatitis affect quality of life? A prospective study with 128 patients evaluating different treatment modalities.

Hapa A, Aksoy B, Polat M, Aslan U, Atakan N.

J Dermatolog Treat. 2011 Aug;22(4):215-20. doi: 10.3109/09546631003675450. Epub 2010 Aug 30.

PMID:
20804437
[PubMed - indexed for MEDLINE]
16.

Recurrent aphthous stomatitis in Behçet's disease: clinical features and correlation with systemic disease expression and severity.

Krause I, Rosen Y, Kaplan I, Milo G, Guedj D, Molad Y, Weinberger A.

J Oral Pathol Med. 1999 May;28(5):193-6.

PMID:
10226940
[PubMed - indexed for MEDLINE]
17.

Oral health is impaired in Behçet's disease and is associated with disease severity.

Mumcu G, Ergun T, Inanc N, Fresko I, Atalay T, Hayran O, Direskeneli H.

Rheumatology (Oxford). 2004 Aug;43(8):1028-33. Epub 2004 May 25.

PMID:
15161982
[PubMed - indexed for MEDLINE]
Free Article
18.

Oral aphthosis: management gaps and recent advances.

Liang MW, Neoh CY.

Ann Acad Med Singapore. 2012 Oct;41(10):463-70.

PMID:
23138144
[PubMed - indexed for MEDLINE]
Free Article
19.

Clinical and immunological effects of azithromycin in Behçet's disease.

Mumcu G, Ergun T, Elbir Y, Eksioglu-Demiralp E, Yavuz S, Atalay T, Direskeneli H.

J Oral Pathol Med. 2005 Jan;34(1):13-6.

PMID:
15610401
[PubMed - indexed for MEDLINE]
20.

The anti-Helicobacter pylori antibiotherapy for the treatment of recurrent oral aphthous ulcers in a patient with Behcet's syndrome.

Yildirim B, Oztürk MA, Unal S.

Rheumatol Int. 2009 Feb;29(4):477-8. doi: 10.1007/s00296-008-0709-2. Epub 2008 Sep 20. No abstract available.

PMID:
18802701
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk